Bram is an Investor Engagement Officer at the Access to Medicine Foundation. He supports the Foundation’s ongoing engagement with institutional investors. The Foundation works with a variety of stakeholder groups, including healthcare analysts and ESG professionals, to improve their knowledge of how pharmaceutical companies manage risks and opportunities related to access to medicine. So far, more than 120 institutional investors have pledged their support by signing the Access to Medicine Index Investor Statement. Together, these investors manage assets in excess of USD 21 trillion.
Bram is a pharmacist by training, and holds a Master’s degree in Pharmacy from Utrecht University School of Pharmacy. He completed his Master’s thesis at the Utrecht WHO Collaborating Centre for Pharmaceutical Policy and Regulation, where he contributed to the analysis of the robustness of an adapted Sustainable Development Goal indicator 3.b.3., which measures access to medicine for children.